Cannara Biotech Inc (LOVE) — Strategic Asset Allocation Index
Cannara Biotech Inc (LOVE) has a Strategic Asset Allocation Index of 122.3% as of February 2023. Strategic assets (PP&E of CA$87.76 Million plus long-term investments of CA$-) total CA$87.76 Million, measured against net assets of CA$71.77 Million. A higher index reflects capital-intensive or investment-heavy strategies where strategic assets dominate the equity base.
SAAI
Strategic Assets
PP&E
Net Assets
Cannara Biotech Inc Strategic Asset Allocation Index (2018–2022)
This chart shows how Cannara Biotech Inc's Strategic Asset Allocation Index has evolved across 5 annual periods from 2018 to 2022. As of February 2023, the index stands at 122.3%, representing strategic assets of CA$87.76 Million against net assets of CA$71.77 Million CAD. Explore Cannara Biotech Inc cash flow conversion to assess how effectively this company generates cash.
Annual Strategic Asset Allocation Index for Cannara Biotech Inc (2018–2022)
The table below presents the year-by-year Strategic Asset Allocation Index for Cannara Biotech Inc from 2018 to 2022, covering 5 annual filings. Each row shows PP&E, long-term investments, strategic assets combined, net assets, the index percentage, and the change in percentage points compared to the prior year. For the full company profile including market capitalisation, see market cap of Cannara Biotech Inc.
| Year | SAAI | Strategic Assets (CAD) | PP&E | LT Investments | Net Assets | Change (pp) |
|---|---|---|---|---|---|---|
| 2022 | 125.0% | CA$83.40 Million | CA$83.40 Million | CA$- | CA$66.74 Million | ▲ +13.1 pp |
| 2021 | 111.9% | CA$71.75 Million | CA$71.75 Million | CA$- | CA$64.12 Million | ▼ -1.9 pp |
| 2020 | 113.8% | CA$43.64 Million | CA$43.64 Million | CA$- | CA$38.36 Million | ▲ +35.1 pp |
| 2019 | 78.6% | CA$39.26 Million | CA$39.26 Million | CA$- | CA$49.93 Million | ▼ -15.1 pp |
| 2018 | 93.8% | CA$13.82 Million | CA$13.82 Million | CA$- | CA$14.74 Million | — |